Kadesh EYE RELIEF DROPS Recall: Non-sterile production risk
Kadesh International recalls EYE RELIEF DROPS due to non-sterile manufacturing. All bottles without expiration dates are affected. Consumers should contact the company for details.
Lower-risk recall
Non-Sterility: Product manufactured under non-sterile production conditions.
Contact the company
What happened, in plain English
Kadesh International is recalling EYE RELIEF DROPS bottles that were manufactured under non-sterile conditions. This could lead to infections if the product is used. The recall affects all bottles without expiration dates. Read more at govinfonow.com/recall/39442-kadesh-eye-relief-drops-recall-non-sterile-production-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39442-kadesh-eye-relief-drops-recall-non-sterile-production-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0250-2019
Cite this page
“Kadesh EYE RELIEF DROPS Recall: Non-sterile production risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39442-kadesh-eye-relief-drops-recall-non-sterile-production-risk. Based on FDA recall #D-0250-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0250-2019%22&limit=1).
Why it’s dangerous
The product was made without sterile conditions, which increases the chance of contamination. This could cause eye infections if the drops are used. The risk is low but not zero.
Who’s affected
People who own or use the EYE RELIEF DROPS bottles with NDC#7079600115 and UPC 7 36972 16799 0. Those with sensitive eyes or existing eye conditions may be at higher risk.
How to tell if you have this one
Check for the bottle label with NDC#7079600115 and UPC 7 36972 16799 0. All bottles do not have expiration dates.
- Brand
Kadesh- Product
puriton EYE RELIEF DROPS, 0.5 oz (15 ml) bottle, Kadesh Inc., NDC#7079600115, UPC 7 36972 16799 0- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC#7079600115 and UPC 7 36972 16799 0 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Product was distributed via online stores and retail distributors Nationwide in the USA, Uruguay, Canada, China, Dominican Republic, Korea, and Vietnam.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 4.2 years after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0250-2019 (November 5, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0250-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.